Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Fostamatinib

Fostamatinib

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Fostamatinib

17 trials tracked of Fostamatinib: 8 in phase 3 or 4 and 2 with published results. The most-cited published study has 62 citations.

17Trials tracked
8Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 8 Phase 2 9
  1. Phase 3 Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Completed · 62 cited
  2. Phase 3 Novel Experimental COVID-19 Therapies Affecting Host Response Completed · 52 cited
  3. Phase 3 A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Completed
  4. Phase 3 Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding. Completed
  5. Phase 3 Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist Completed
  6. Phase 3 A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Completed
Show 11 more trials
  1. Phase 3 A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Completed
  2. Phase 3 Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. Completed
  3. Phase 2 Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer Completed
  4. Phase 2 Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) Completed
  5. Phase 2 Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma Completed
  6. Phase 2 A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... Completed
  7. Phase 2 Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) Completed
  8. Phase 2 Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis Completed
  9. Phase 2 Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma Completed
  10. Phase 2 Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis Completed
  11. Phase 2 Fostamatinib for Hospitalized Adults With COVID-19 Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.